{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:43:25Z","timestamp":1779237805313,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.kint.2017.11.017","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T03:11:18Z","timestamp":1519960278000},"page":"1118-1130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Intranuclear delivery of the transcription modulation domain of Tbet-improved lupus nephritis in (NZB\/NZW) F1 lupus-prone mice"],"prefix":"10.1016","volume":"93","author":[{"given":"Jae-Seung","family":"Moon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin Hee","family":"Mun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Young","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Dong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Yoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Su","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Chang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sankar","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred L.M.","family":"Bothwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Kyou","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2017.11.017_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematous","volume":"358","author":"Anisur","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.11.017_bib2","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.017_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/BOR.0000000000000082","article-title":"The role of T cells in systemic lupus erythematosus: an update","volume":"26","author":"Konya","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.kint.2017.11.017_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrrheum.2010.60","article-title":"T\u00a0cells as therapeutic targets in SLE","volume":"6","author":"Crisp\u00edn","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.kint.2017.11.017_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A\u00a0novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.kint.2017.11.017_bib6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.immuni.2004.09.010","article-title":"Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes","volume":"21","author":"Lovett-Racke","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2017.11.017_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2009.07.007","article-title":"Encephalitogenic T cells that stably express both T-bet and ROR\u03b3t consistently produce IFN\u03b3 but have a spectrum of IL-17 profiles","volume":"215","author":"Abromson-Leeman","year":"2009","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.kint.2017.11.017_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00439-004-1146-2","article-title":"Identification of a novel type 1 diabetes susceptibility gene, T-bet","volume":"115","author":"Sasaki","year":"2004","journal-title":"Hum Genet"},{"key":"10.1016\/j.kint.2017.11.017_bib9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/gut.2003.024190","article-title":"T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn\u2019s disease","volume":"53","author":"Matsuoka","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.kint.2017.11.017_bib10","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.20082584","article-title":"T-bet is essential for encephalitogenicity of both Th1 and Th17 cells","volume":"206","author":"Yang","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2017.11.017_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.immuni.2014.01.002","article-title":"The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-\u03b3-producing T helper 17 cells","volume":"40","author":"Wang","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2017.11.017_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1476-5381.2009.00190.x","article-title":"Therapeutic antibodies: successes, limitations and hopes for the future","volume":"157","author":"Chames","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.kint.2017.11.017_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11938-013-0004-5","article-title":"Therapeutic drug monitoring of anti-TNF therapy in inflammatory bowel disease","volume":"12","author":"Scott","year":"2014","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.kint.2017.11.017_bib14","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/annrheumdis-2012-202844","article-title":"Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids","volume":"72","author":"Condon","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2017.11.017_bib15","doi-asserted-by":"crossref","first-page":"ii62","DOI":"10.1136\/annrheumdis-2012-202195","article-title":"Could we abandon cyclophosphamide in systemic vasculitis and lupus nephritis?","volume":"72","author":"Kallenberg","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2017.11.017_bib16","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood-2005-04-1393","article-title":"T-bet is required for optimal proinflammatory CD4+ T-cell trafficking","volume":"106","author":"Lord","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.kint.2017.11.017_bib17","doi-asserted-by":"crossref","first-page":"8510","DOI":"10.1128\/MCB.01615-07","article-title":"T-bet's ability to regulate individual target genes requires the conserved T-box domain to recruit histone methyltransferase activity and a separate family member-specific transactivation domain","volume":"27","author":"Lewis","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.kint.2017.11.017_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.gene.2006.03.016","article-title":"T-box proteins differentially activate the expression of the endogenous interferon \u03b3 gene versus transfected reporter genes in non-immune cells","volume":"377","author":"Butz","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.kint.2017.11.017_bib19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/gtc.12328","article-title":"Eomesodermin promotes interferon-\u03b3 expression and binds to multiple conserved noncoding sequences across the Ifng locus in mouse thymoma cell lines","volume":"21","author":"Fukuoka","year":"2016","journal-title":"Genes Cells"},{"key":"10.1016\/j.kint.2017.11.017_bib20","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1136\/annrheumdis-2013-203827","article-title":"Which B-cell subset should we target in lupus?","volume":"72","author":"Ferraccioli","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2017.11.017_bib21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.20052438","article-title":"TLR9\/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE","volume":"203","author":"Ehlers","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2017.11.017_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2567.2008.02835.x","article-title":"Long-term administration of IgG2a anti-NK1. 1 monoclonal antibody ameliorates lupus-like disease in NZB\/W mice in spite of an early worsening induced by an IgG2a-dependent BAFF\/BLyS production","volume":"125","author":"Post\u00f3l","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.kint.2017.11.017_bib23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrneph.2010.170","article-title":"Treatment of proliferative lupus nephritis: a slowly changing landscape","volume":"7","author":"Tesar","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2017.11.017_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2007.070367","article-title":"EULAR recommendations for the management of systemic lupus erytematosus (SLE) report of a task force of the european standing committee for international clinical studies including therapeutics (ESCISIT)","volume":"67","author":"Bertsias","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2017.11.017_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/0961203308100481","article-title":"European consensus statement on the terminology used in the management of lupus glomerulonephritis","volume":"18","author":"Gordon","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2017.11.017_bib26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3109\/03009742.2014.887769","article-title":"Belimumab may not prevent lupus nephritis in serologically active patients with ongoing non-renal disease activity","volume":"43","author":"Sj\u00f6wall","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.kint.2017.11.017_bib27","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0961203313483376","article-title":"Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis","volume":"22","author":"Davies","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2017.11.017_bib28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/ki.2012.242","article-title":"Kidney-infiltrating CD4+ T-cell clones promote nephritis in lupus-prone mice","volume":"82","author":"Okamoto","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.017_bib29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1084\/jem.166.3.798","article-title":"In\u00a0vivo treatment of (NZB X NZW) F1 lupus-like nephritis with monoclonal antibody to gamma interferon","volume":"166","author":"Jacob","year":"1987","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2017.11.017_bib30","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/rheumatology\/kel029","article-title":"Imbalance of Th1\/Th2 transcription factors in patients with lupus nephritis","volume":"45","author":"Chan","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2017.11.017_bib31","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/ard.2006.063123","article-title":"Intrarenal cytokine gene expression in lupus nephritis","volume":"66","author":"Chan","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2017.11.017_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.semnephrol.2006.09.007","article-title":"T\u00a0cells and B cells in lupus nephritis","volume":"27","author":"Foster","year":"2007","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2017.11.017_bib33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1126\/science.1103336","article-title":"T\u00a0helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3","volume":"307","author":"Hwang","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.kint.2017.11.017_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ni.1969","article-title":"T-bet represses TH17 differentiation by preventing Runx1-mediated activation of the gene encoding ROR [gamma] t","volume":"12","author":"Lazarevic","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2017.11.017_bib35","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.immuni.2012.10.010","article-title":"Interferon-\u03b3 excess leads to pathogenic accumulation of follicular helper T cells and germinal centers","volume":"37","author":"Lee","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2017.11.017_bib36","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/art.37955","article-title":"Soluble receptor for advanced glycation end products alleviates nephritis in (NZB\/NZW) F1 mice","volume":"65","author":"Lee","year":"2013","journal-title":"Arthritis Rheum"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817308530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817308530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T03:06:15Z","timestamp":1651374375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253817308530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0085253817308530"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2017.11.017","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranuclear delivery of the transcription modulation domain of Tbet-improved lupus nephritis in (NZB\/NZW) F1 lupus-prone mice","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2017.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}